Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

OHSU scientists locate, characterize key hormone involved in appetite control

21.02.2003


Increasing hormone causes increase of appetite, eating



Researchers at Oregon Health & Science University (OHSU) have identified a key hormone involved in appetite control and demonstrated its effect on the brain. Scientists have shown that the hormone, called ghrelin, activates specialized neurons in the hypothalamus involved in weight regulation. The research involved scientists at several collaborating institutions, including: Yale Medical School, Baylor College of Medicine, the University of Alberta and Lilly Research Laboratories. The results are printed in the Feb. 20 edition of the journal Neuron.

Researchers believe this information could be used to develop drugs aimed at stimulating appetite in patients who have undergone extreme weight loss due to illness, a condition known as cachexia. These pharmaceuticals could also assist children who are developing at a slower than normal rate. Conversely, drugs aimed at limiting production of the hormone might be developed to reduce appetite for those battling severe obesity.


"Ghrelin is a hormone produced in the stomach with the ability to stimulate feeding when introduced to specialized weight regulation brain cells called neuropeptide Y neurons. In fact, past research has shown that when ghrelin levels are increased in mice for an extended period, the mice gain weight," said Michael Cowley, Ph.D., an assistant scientist in the Division of Neuroscience at the OHSU Oregon National Primate Research Center and lead author of the study. "In both mice and humans, ghrelin levels increase naturally in response to weight loss or reduced caloric intake. As expected, the hormone diminishes in response to food intake. In other words, it’s believed to be part of the body’s natural signaling system which informs the brain when it’s time to eat."

To pinpoint and witness the effects of ghrelin in the brain, the scientists used a method pioneered by OHSU researchers Cowley, Roger Cone, Ph.D., and Malcolm Low, M.D., Ph.D. The researchers used a fluorescent protein to highlight certain neurons, making the brain cells distinguishable from other surrounding neurons. They then used tiny electrodes to record cell activity in response to ghrelin.

"It is remarkable how such a relatively small group of interconnected neurons deep in the brain coordinate the daily signals of hunger and satiety with the body’s long-term energy stores to normally maintain a constant body weight," said Low, a scientist in the Vollum Institute at OHSU.

The research team also located a new source for ghrelin production in the body. The site is located in a section of the hypothalamus that had no previously known function and that is near the brain region affected by the hormone.

"This research shows that there are two sites where increased appetite may be generated, the stomach and the brain," explained Cone, a senior scientist at the OHSU Vollum Institute. "We hope future research will hopefully distinguish between the roles of these two production sites so that we may better understand weight regulation and energy homeostasis in the body."

These latest findings follow a study published in August 2002 that identified and characterized peripheral hormone peptide YY (PYY). PYY appears to have the opposite effect as ghrelin – reducing appetite instead of increasing it. OHSU researchers and their collaborators found that by introducing PYY into the bloodstreams of both humans and mice, a temporary, but measurable drop in appetite and food ingestion occurred.


###
This research was sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Center for Research Resources, both components of the National Institutes of Health.


Jim Newman | EurekAlert!
Further information:
http://www.ohsu.edu/

More articles from Life Sciences:

nachricht MicroRNA helps cancer evade immune system
19.09.2017 | Salk Institute

nachricht Ruby: Jacobs University scientists are collaborating in the development of a new type of chocolate
18.09.2017 | Jacobs University Bremen gGmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>